GABA-Synthesizing Enzymes in Calbindin and Calretinin Neurons in Monkey Prefrontal Cortex

Cerebral Cortex

Volumn 26, Issue 5, 2016, Pages 2191-2204

  Rocco, Brad R ^a   Sweet, Robert A ^a,b   Lewis, David A ^a   Fish, Kenneth N ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

GAD65; GAD67; glutamic acid decarboxylase; somatostatin; vasoactive intestinal peptide

Indexed keywords

4 AMINOBUTYRIC ACID; CALBINDIN; CALRETININ; GLUTAMATE DECARBOXYLASE 65; GLUTAMATE DECARBOXYLASE 67; MESSENGER RNA; SOMATOSTATIN; VASOACTIVE INTESTINAL POLYPEPTIDE; 4 AMINOBUTYRIC ACID RECEPTOR; GLUTAMATE DECARBOXYLASE; GLUTAMATE DECARBOXYLASE 1; GLUTAMATE DECARBOXYLASE 2;

ADULT; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN NERVE CELL; CELL SUBPOPULATION; FLUORESCENCE MICROSCOPY; GABAERGIC SYSTEM; HAPLORHINI; MALE; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN EXPRESSION; SYNTHESIS; ANIMAL; BIOSYNTHESIS; ENZYMOLOGY; METABOLISM; NERVE ENDING; RHESUS MONKEY;

ANIMALS; CALBINDIN 2; CALBINDINS; GABAERGIC NEURONS; GAMMA-AMINOBUTYRIC ACID; GLUTAMATE DECARBOXYLASE; MACACA MULATTA; MALE; PREFRONTAL CORTEX; PRESYNAPTIC TERMINALS; SOMATOSTATIN; VASOACTIVE INTESTINAL PEPTIDE;

EID: 84965180970     PISSN: 10473211     EISSN: 14602199     Source Type: Journal    
DOI: 10.1093/cercor/bhv051     Document Type: Article

References (67)

1. Akbarian S, Kim JJ, Potkin SG, Hagman JO, Tafazzoli A, Bunney WE Jr, Jones EG. 1995. Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics. Arch Gen Psychiatry. 52:258-266.
2. Ascoli GA, Alonso-Nanclares L, Anderson SA, Barrionuevo G, Benavides-Piccione R, Burkhalter A, Buzsaki G, Cauli B, Defelipe J, Fairen A, et al. 2008. Petilla terminology: nomenclature of features of GABAergic interneurons of the cerebral cortex. Nat Rev Neurosci. 9:557-568.
3. Bakst I, Morrison JH, Amaral DG. 1985. The distribution of somatostatin-like immunoreactivity in the monkey hippocampal formation. J Comp Neurol. 236:423-442.
4. Barinka F, Druga R. 2010. Calretinin expression in the mammalian neocortex: a review. Physiol Res. 59:665-677.
5. Benoit R, Bohlen P, Ling N, Esch F, Baird A, Ying SY, Wehrenberg WB, Guillemin R, Morrison JH, Bakhit C, et al. 1985. Somatostatin-28(1-12)-like peptides. In: Proceedings of the 3rd International Symposium on Somatostatin, Montreal, New York: Plenum Press.
6. Benoit R, Ling N, Alford B, Guillemin R. 1982. Seven peptides derived from pro-somatostatin in rat brain. Biochem Biophys Res Commun. 107:944-950.
7. Bernard C, Cossart R, Hirsch JC, Esclapez M, Ben-Ari Y. 2000. What is GABAergic inhibition? How is it modified in epilepsy? Epilepsia. 41(Suppl 6):S90-S95.
8. Chang YC, Gottlieb DI. 1988. Characterization of the proteins purified with monoclonal antibodies to glutamic acid decarboxylase. J Neurosci. 8:2123-2130.
9. Conde F, Lund JS, Jacobowitz DM, Baimbridge KG, Lewis DA. 1994. Local circuit neurons immunoreactive for calretinin, calbindin D-28k or parvalbumin in monkey prefrontal cortex: distribution and morphology. J Comp Neurol. 341:95-116.
10. Curley AA, Arion D, Volk DW, Asafu-Adjei JK, Sampson AR, Fish KN, Lewis DA. 2011. Cortical deficits of glutamic acid decarboxylase 67 expression in schizophrenia: clinical, protein, and cell type-specific features. Am J Psychiatry. 168:921-929.
11. DeFelipe J. 1999. Chandelier cells and epilepsy. Brain. 122(Pt 10):1807-1822.
12. DeFelipe J, Hendry SHC, Jones EG. 1989. Synapses of double bouquet cells in monkey cerebral cortex visualized by calbindin immunoreactivity. Brain Res. 503:49-54.
13. DeFelipe J, Hendry SH, Jones EG. 1989. Visualization of chandelier cell axons by parvalbumin immunoreactivity in monkey cerebral cortex. Proc Natl Acad Sci USA. 86:2093-2097.
14. del Rio MR, DeFelipe J. 1996. Colocalization of calbindin D-28k, calretinin, and GABA immunoreactivities in neurons of the human temporal cortex. J Comp Neurol. 369:472-482.
15. del Rio MR, DeFelipe J. 1997. Synaptic connections of calretinin-immunoreactive neurons in the human neocortex. J Neurosci. 17:5143-5154.
16. Donato F, Rompani SB, Caroni P. 2013. Parvalbumin-expressing basket-cell network plasticity induced by experience regulates adult learning. Nature. 504:272-276.
17. Dugladze T, Schmitz D, Whittington MA, Vida I, Gloveli T. 2012. Segregation of axonal and somatic activity during fast network oscillations. Science. 336:1458-1461.
18. Duncan CE, Webster MJ, Rothmond DA, Bahn S, Elashoff M, Shannon Weickert C. 2010. Prefrontal GABA(A) receptor alpha-subunit expression in normal postnatal human development and schizophrenia. J Psychiatr Res. 44:673-681.
19. Fish KN, Sweet RA, Deo AJ, Lewis DA. 2008. An automated segmentation methodology for quantifying immunoreactive puncta number and fluorescence intensity in tissue sections. Brain Res. 1240:62-72.
20. Fish KN, Sweet RA, Lewis DA. 2011. Differential distribution of proteins regulating GABA synthesis and reuptake in axon boutons of subpopulations of cortical interneurons. Cereb Cortex. 21:2450-2460.
21. Freund TF, Buzsáki G, Leon A, Baimbridge KG, Somogyi P. 1990. Relationship of neuronal vulnerability and calcium binding protein immunoreactivity in ischemia. Exp Brain Res. 83:55-66.
22. Gabbott PL, Bacon SJ. 1996. Local circuit neurons in the medial prefrontal cortex (areas 24a,b,c, 25 and 32) in the monkey: II. Quantitative areal and laminar distributions. J Comp Neurol. 364:609-636.
23. Gabbott PL, Bacon SJ. 1997. Vasoactive intestinal polypeptide containing neurones in monkey medial prefrontal cortex (mPFC): colocalisation with calretinin. Brain Res. 744:179-184.
24. Glausier JR, Fish KN, Lewis DA. 2014. Altered parvalbumin basket cell inputs in the dorsolateral prefrontal cortex of schizophrenia subjects. Mol Psychiatry. 19:30-36.
25. Gonchar Y, Burkhalter A. 1997. Three distinct families of GABAergic neurons in rat visual cortex. Cereb Cortex. 7:347-358.
26. Gottlieb DI, Chang YC, Schwob JE. 1986. Monoclonal antibodies to glutamic acid decarboxylase. Proc Natl Acad Sci USA. 83:8808-8812.
27. Guidotti A, Auta J, Davis JM, Di-Giorgi-Gerevini V, Dwivedi Y, Grayson DR, Impagnatiello F, Pandey G, Pesold C, Sharma R, et al. 2000. Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study. Arch Gen Psychiatry. 57:1061-1069.
28. Gulyas AI, Szabo GG, Ulbert I, Holderith N, Monyer H, Erdelyi F, Szabo G, Freund TF, Hajos N. 2010. Parvalbumin-containing fast-spiking basket cells generate the field potential oscillations induced by cholinergic receptor activation in the hippocampus. J Neurosci. 30:15134-15145.
29. Guo C, Stella SL Jr, Hirano AA, Brecha NC. 2009. Plasmalemmal and vesicular gamma-aminobutyric acid transporter expression in the developing mouse retina. J Comp Neurol. 512:6-26.
30. Hashimoto T, Arion D, Unger T, Maldonado-Aviles JG, Morris HM, Volk DW, Mirnics K, Lewis DA. 2008. Alterations in GABA-related transcriptome in the dorsolateral prefrontal cortex of subjects with schizophrenia. Mol Psychiatry. 13:147-161.
31. Hashimoto T, Volk DW, Eggan SM, Mirnics K, Pierri JN, Sun Z, Sampson AR, Lewis DA. 2003. Gene expression deficits in a subclass of GABA neurons in the prefrontal cortex of subjects with schizophrenia. J Neurosci. 23:6315-6326.
32. Hayes TL, Lewis DA. 1992. Nonphosphorylated neurofilament protein and calbindin immunoreactivity in layer III pyramidal neurons of human neocortex. Cereb Cortex. 2:56-67.
33. Hendry SHC, Schwark HD, Jones EG, Yan J. 1987. Numbers and proportions of GABA-immunoreactive neurons in different areas of monkey cerebral cortex. J Neurosci. 7:1503-1519.
34. Hof PR, Morrison JH. 1991. Neocortical neuronal subpopulations labeled by a monoclonal antibody to calbindin exhibit differential vulnerability in Alzheimer's disease. Exp Neurol. 111:293-301.
35. Hoftman GD, Volk DW, Bazmi HH, Li S, Sampson AR, Lewis DA. 2015. Altered cortical expression of GABA-related genes in schizophrenia: illness progression vs developmental disturbance. Schizophr Bull. 41:180-191.
36. Hyde TM, Lipska BK, Ali T, Mathew SV, Law AJ, Metitiri OE, Straub RE, Ye T, Colantuoni C, Herman MM, et al. 2011. Expression of GABA signaling molecules KCC2, NKCC1, and GAD1 in cortical development and schizophrenia. J Neurosci. 31:11088-11095.
37. Impagnatiello F, Guidotti AR, Pesold C, Dwivedi Y, Caruncho H, Pisu MG, Uzunov DP, Smalheiser NR, Davis JM, Pandey GN, et al. 1998. A decrease of reelin expression as a putative vulnerability factor in schizophrenia. Proc Natl Acad Sci USA. 95:15718-15723.
38. Kanaani J, el-Husseini Ael D, Aguilera-Moreno A, Diacovo JM, Bredt DS, Baekkeskov S. 2002. A combination of three distinct trafficking signals mediates axonal targeting and presynaptic clustering of GAD65. J Cell Biol. 158:1229-1238.
39. Kanaani J, Kolibachuk J, Martinez H, Baekkeskov S. 2010. Two distinct mechanisms target GAD67 to vesicular pathways and presynaptic clusters. J Cell Biol. 190:911-925.
40. Kepecs A, Fishell G. 2014. Interneuron cell types are fit to function. Nature. 505:318-326.
41. Kimoto S, Bazmi HH, Lewis DA. 2014. Lower expression of glutamic acid decarboxylase 67 in the prefrontal cortex in schizophrenia: contribution of altered regulation by Zif268. Am J Psychiatry. 171:969-978.
42. Kubota Y, Hattori R, Yui Y. 1994. Three distinct subpopulations of GABAergic neurons in rat frontal agranular cortex. Brain Res. 649:159-173.
43. Lau CG, Murthy VN. 2012. Activity-dependent regulation of inhibition via GAD67. J Neurosci. 32:8521-8531.
44. Lewis DA, Campbell MJ, Morrison JH. 1986. An immunohistochemical characterization of somatostatin-28 and somatostatin-28 (1-12) in monkey prefrontal cortex. J Comp Neurol. 248:1-18.
45. Lewis DA, Lund JS. 1990. Heterogeneity of chandelier neurons in monkey neocortex: corticotropin-releasing factor- and parvalbumin-immunoreactive populations. J Comp Neurol. 293:599-615.
46. Lovett-Barron M, Kaifosh P, Kheirbek MA, Danielson N, Zaremba JD, Reardon TR, Turi GF, Hen R, Zemelman BV, Losonczy A. 2014. Dendritic inhibition in the hippocampus supports fear learning. Science. 343:857-863.
47. Lovett-Barron M, Turi GF, Kaifosh P, Lee PH, Bolze F, Sun XH, Nicoud JF, Zemelman BV, Sternson SM, Losonczy A. 2012. Regulation of neuronal input transformations by tunable dendritic inhibition. Nat Neurosci. 15:423-430, S421-423.
48. Maccaferri G, Roberts JD, Szucs P, Cottingham CA, Somogyi P. 2000. Cell surface domain specific postsynaptic currents evoked by identified GABAergic neurones in rat hippocampus in vitro. J Physiol. 524(Pt 1):91-116.
49. Melchitzky DS, Lewis DA. 2008. Dendritic-targeting GABA neurons in monkey prefrontal cortex: comparison of somatostatin- and calretinin-immunoreactive axon terminals. Synapse. 62:456-465.
50. Melchitzky DS, Sesack SR, Lewis DA. 1999. Parvalbumin-immunoreactive axon terminals in macaque monkey and human prefrontal cortex: laminar, regional, and target specificity of type I and type II synapses. J Comp Neurol. 408:11-22.
51. Mirnics K, Middleton FA, Marquez A, Lewis DA, Levitt P. 2000. Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex. Neuron. 28:53-67.
52. Morrison JH, Benoit R, Magistretti PJ, Bloom FE. 1983. Immunohistochemical distribution of pro-somatostatin-related peptides in cerebral cortex. Brain Res. 262:344-351.
53. Oeth KM, Lewis DA. 1993. Postnatal development of the cholecystokinin innervation of monkey prefrontal cortex. J Comp Neurol. 336:400-418.
54. Pfeffer CK, Xue M, He M, Huang ZJ, Scanziani M. 2013. Inhibition of inhibition in visual cortex: the logic of connections between molecularly distinct interneurons. Nat Neurosci. 16:1068-1076.
55. Pi HJ, Hangya B, Kvitsiani D, Sanders JI, Huang ZJ, Kepecs A. 2013. Cortical interneurons that specialize in disinhibitory control. Nature. 503:521-524.
56. Rajkowska G, O'Dwyer G, Teleki Z, Stockmeier CA, Miguel-Hidalgo JJ. 2007. GABAergic neurons immunoreactive for calcium binding proteins are reduced in the prefrontal cortex in major depression. Neuropsychopharmacology. 32:471-482.
57. Ridler TW, Calvard S. 1978. Picture thresholding using an iterative selection method. IEEE Trans Sys Man Cyber. SMC-8:630-632.
58. Rogers JH. 1992. Immunohistochemical markers in rat cortex: co-localization of calretinin and calbindin-D28k with neuropeptides and GABA. Brain Res. 587:147-157.
59. Schwaller B, Buchwald P, BlÅmcke I, Celio MR, Hunziker W. 1993. Characterization of a polyclonal antiserum against the purified human recombinant calcium-binding protein calretinin. Cell Calcium. 14:601-610.
60. Straub RE, Lipska BK, Egan MF, Goldberg TE, Callicott JH, Mayhew MB, Vakkalanka RK, Kolachana BS, Kleinman JE, Weinberger DR. 2007. Allelic variation in GAD1 (GAD67) is associated with schizophrenia and influences cortical function and gene expression. Mol Psychiatry. 12:854-869.
61. Thune JJ, Uylings HBM, Pakkenberg B. 2001. No deficit in total number of neurons in the prefrontal cortex in schizophrenics. J Psychiatr Res. 35:15-21.
62. Tu JC, Xiao B, Naisbitt S, Yuan JP, Petralia RS, Brakeman P, Doan A, Aakalu VK, Lanahan AA, Sheng M, et al. 1999. Coupling of mGluR/Homer and PSD-95 complexes by the Shank family of postsynaptic density proteins. Neuron. 23:583-592.
63. Vawter MP, Crook JM, Hyde TM, Kleinman JE, Weinberger DR, Becker KG, Freed WJ. 2002. Microarray analysis of gene expression in the prefrontal cortex in schizophrenia: a preliminary study. Schizophr Res. 58:11-20.
64. Volk DW, Austin MC, Pierri JN, Sampson AR, Lewis DA. 2000. Decreased glutamic acid decarboxylase67 messenger RNA expression in a subset of prefrontal cortical gammaaminobutyric acid neurons in subjects with schizophrenia. Arch Gen Psychiatry. 57:237-245.
65. Wang F, Flanagan J, Su N, Wang LC, Bui S, Nielson A, Wu X, Vo HT, Ma XJ, Luo Y. 2012. RNAscope: a novel in situ RNA analysis platform for formalin-fixed, paraffin-embedded tissues. J Mol Diagn. 14:22-29.
66. Wang Y, Toledo-Rodriguez M, Gupta A, Wu C, Silberberg G, Luo J, Markram H. 2004. Anatomical, physiological and molecular properties of Martinotti cells in the somatosensory cortex of the juvenile rat. J Physiol. 561:65-90.
67. Xu H, Jeong H-Y, Tremblay R, Rudy B. 2013. Neocortical somatostatin-expressing GABAergic interneurons disinhibit the thalamorecipient layer 4. Neuron. 77:155-167.